share_log

Ascendiant Capital Initiates Coverage On Heart Test Laboratories With Buy Rating, Announces Price Target of $3.3

Benzinga Real-time News ·  Jan 30, 2023 08:08

Ascendiant Capital analyst Edward Woo initiates coverage on Heart Test Laboratories (NASDAQ:HSCS) with a Buy rating and announces Price Target of $3.3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment